Patients with a cardiovascular disease
Conditions
Interventions
Group 1: placebo and monitoring (rehab diary) - duration 14 days:
The participants receive a placebo spray (filled with water) at the beginning of their rehabilitation process, which they have to tak
Sponsors
Universität Graz
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: patients with a cardiac disease
Exclusion criteria
Exclusion criteria: diagnosed cognitive disorders (such as Alzheimer's disease or vascular dementia), severe psychiatric comorbidity (e.g. acute psychotic symptoms)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Three questionnaires presented before and after the two weeks: - Cardiac Anxiety Questionnaire (HAF-17; Hoyer & Eifert, 2009) - Pittsburgh Sleep Quality Index (Buysse et al., 1988) - Warwick-Edinburgh Mental Well-Being Scale in the German version (WEMWBS; Bachinger & Lang, 2013): | — |
Secondary
| Measure | Time frame |
|---|---|
| In a rehabilitation diary, the test subjects fill in the following questions about their current emotional well-being every day: - How did you sleep today? (0-10) - How well do you feel? (0-10) - How anxious do you feel about your heart today? (0-10) - Have you taken any medication today? If yes, which one? - Have you taken your placebo spray today? (only in the placebo group) In addition, the respondents each complete two items to assess the effectiveness of the placebo (before and after the two weeks): - How much do you think the placebo will help you? (0-10) - How much do you think the placebo has helped you? (0-10) In addition, a semi-structured interview was used to ask about the respondents' previous experience with placebos. | — |
Countries
Austria
Contacts
Public ContactSandra Tanzmeister
Universität Graz
Outcome results
None listed